Mike Carter tried to rid his body of hepatitis C twice before, using miserable and less-effective treatments that came before a new class of drugs that is reshaping how the potentially fatal liver disease is found and treated.
Carter, 63, of Delaware, is one of the new success stories. There’s no sign of the virus in his blood after more than four decades of living with it.
“This has totally changed the landscape. It’s gone from nasty drugs with a lot of psychiatric side effects to minimal side effects,” said Dr. Robert Kirkpatrick, a gastroenterologist at Ohio State University’s Wexner Medical Center and Carter’s doctor.